Product Images Tamsulosin Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Tamsulosin Hydrochloride NDC 68071-5118 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PDP - 68071 5118 1
This appears to be a label or packaging information for Tamsulosin HCI 0.4mg capsules made by NuCare Pharmaceuticals. It includes important information about warnings, dosage, ingredients, lot numbers, and an expiration date. The label advises users to consult their doctor about side effects and to keep the medication out of reach of children. The capsules should be stored in a controlled temperature environment.*
Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-Dose Administration of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted and Fed Conditions (n=8) - tamsulosin fig1
The text is a figure caption showing the plasma concentration of Tamsulosin Hydrochloride Capsules 0.4 mg following single-dose administration under fasted and fed conditions. Not available to provide a useful description.*
Figure 2A Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1 - tamsulosin fig2
Figure 2B Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 2 - tamsulosin fig3
Figure 3A Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1 - tamsulosin fig4
The description is: "A figure titled 'Figure 3A Mean Increase in Peak Urine Flow Rate' shows the mean change in peak urine flow rate in mL/sec after treatment with 0.08mg, 0.4mg, and placebo over a period of 7 to 13 weeks as part of Study 1. The number of participants in each group is indicated."*
Figure 3B Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2 - tamsulosin fig5
The graph in Figure 3B shows the mean increase in peak urine flow rate (measured in mL/sec) during Study 2. The graph displays the effect of a 20-week treatment on the flow rate. The x-axis represents the duration of treatment in weeks, and the y-axis represents the increase in peak urine flow rate. The treatment appears to result in a gradual and continuous increase in the flow rate. The labels and markings on the graph are not entirely clear, and some characters are not readable.*
Chemical Structure - tamsulosin str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.